ReviewFrontiers in radiology2025
Self-supervised learning and transformer-based technologies in breast cancer imaging.
Review in Frontiers in radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- MMBCFNet: multi modal hybrid deep learning framework for breast cancer detection using MRI, mammography, and ultrasound images.Journal of ultrasound · 2026Article
- Multi-Parametric Ultrasound Radiomic Kinetics with Machine Learning Ensemble for Early Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer.Diagnostics (Basel, Switzerland) · 2026Article
- Review
- AI-powered radiogenomics: imaging-driven diagnosis and discovery of cancer's molecular and cellular landscape.Molecular genetics and genomics : MGG · 2026Review
- Ensemble Deep Learning-Based High-Precision Framework for Breast Cancer Detection from Histopathological Images.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer is the most common malignancy among women worldwide, and imaging remains critical for early detection, diagnosis, and treatment planning. Recent advances in artificial intelligence (AI), particularly self-supervised learning (SSL) and transformer-based architectures, have opened new opportunities for breast image analysis. SSL offers a label-efficient strategy that reduces reliance on large annotated datasets, with evidence suggesting that it can achieve strong performance. Transformer-based architectures, such as Vision Transformers, capture long-range dependencies and global contextual information, complementing the local feature sensitivity of convolutional neural networks. This study provides a comprehensive overview of recent developments in SSL and transformer models for breast lesion segmentation, detection, and classification, highlighting representative studies in each domain. It also discusses the advantages and current limitations of these approaches and outlines future research priorities, emphasizing that successful clinical translation depends on access to multi-institutional datasets to ensure generalizability, rigorous external validation to confirm real-world performance, and interpretable model designs to foster clinician trust and enable safe, effective deployment in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.